Khepri

Curated by Signal

Reversing chronic inflammation and aging in animals via gene therapy

Overview

Reversing chronic inflammation and aging in animals via gene therapy. The company focuses on metabolic gene therapy to address chronic inflammatory diseases in animals. Their approach targets senescent cells, which contribute to inflammation and tissue damage. By reversing the senescence process, the company aims to restore normal cellular function and reduce inflammation, thereby improving animal health and well-being. Research and clinical trials support the efficacy of this innovative treatment.

Key facts

Founded: 2024
Headquarters: New York City, United States
Stage: Sign up to view
Industry: Health Technology

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

Predictable Surgical Technologies
Provider of an online pharmacy for healthcare products
Health TechnologyHebron, United States
ProcedureCard
Provider of cloud-based software for operating room management
Health TechnologyModesto, United States
Clarity Therapy Associates
Provider of online consultation services with psychotherapists
Health TechnologySan Diego, United States

About Khepri

What does Khepri do?

Reversing chronic inflammation and aging in animals via gene therapy.

Where is Khepri headquartered?

Khepri is headquartered in New York City, United States.

When was Khepri founded?

Khepri was founded in 2024.

Which sector is Khepri in?

Khepri operates in Health Technology.

Who are Khepri's competitors?

Companies similar to Khepri include Predictable Surgical Technologies, ProcedureCard, and Clarity Therapy Associates.